Skip to main content

Showing results for Cancer

IU Simon Comprehensive Cancer Center partners with nation’s top cancer organizations to endorse initiative to increase lung cancer screening in the United States

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.

Cancer center launches new PhD program in translational cancer biology

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center is now offering a new PhD program dedicated to clinically relevant research in cancer biology.

IU School of Medicine  |  Oct 26, 2022

IU cancer center names new director for the world’s only healthy breast tissue bank

Michele Coté, PhD, will serve as director of the Susan G. Komen Tissue Bank at IU Simon Comprehensive Cancer Center.

Chuckstrong Tailgate Gala raises more than $2 million, marking a decade of dedication to IU cancer research

During a celebratory night marking a decade of the Chuckstrong initiative, more than $2 million was raised for research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

IU School of Medicine  |  Aug 05, 2022

IU cancer researchers refining colorectal cancer classification, identifying new targets for treatment using cutting-edge, single-cell technology

Analyzing nearly 500,000 single cells, researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are refining how to classify colorectal cancer and identify new targets to develop effective therapies.

IU School of Medicine  |  May 23, 2022

IU School of Medicine names first Walther Scholar in Psycho-Oncology

Indiana University School of Medicine has named Shelley Johns, PsyD, ABPP, the Walther Scholar in Psycho-Oncology.

IU School of Medicine  |  Apr 26, 2022

Vera Bradley Foundation for Breast Cancer makes $12.5 million commitment to Indiana University School of Medicine

A gift commitment of $12.5 million to Indiana University School of Medicine from the Vera Bradley Foundation for Breast Cancer will support new research to harness immunotherapy for breast cancer treatment.

IU School of Medicine  |  Apr 20, 2022

Study: Vaccine protects most cancer patients from COVID, but risk remains higher for patients with blood cancers

Using the nation’s largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID.

IU School of Medicine  |  Apr 04, 2022

Researchers make important new findings about how to test cancer-fighting drugs

Researchers from Indiana University School of Medicine are discovering new ways to find out how effective a drug might be against cancer.

Christina Griffiths  |  Jan 13, 2022

IU School of Medicine research provides advances in treatment of triple negative breast cancer

Indiana University School of Medicine physician scientist Bryan Schneider, MD is the principal investigator of clinical trial BRE12-158, a randomized clinical study published in the prominent Journal of Clinical Oncology the primary goal of which was to compare survival in women with high-risk (those who did not fully respond to chemotherapy prior to surgery) triple negative breast cancer (TNBC) with a genomically directed therapy versus standard of care.

IU School of Medicine  |  Dec 15, 2021